Publication | Closed Access

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617

UrologyRadiologyRadioligand TherapyGenitourinary CancerMedicineCancer TreatmentProstatic DiseaseOncologyOverall SurvivalResponse Pattern